Premium
Overtreatment and undertreatment of hypertension
Author(s) -
Furberg C. D.,
Berglund G.,
Manolio T. A.,
Psaty B. M.
Publication year - 1994
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.1994.tb01093.x
Subject(s) - medicine , stroke (engine) , blood pressure , intensive care medicine , myocardial infarction , randomized controlled trial , clinical trial , public health , pathology , mechanical engineering , engineering
. Furberg CD, Berglund G. Manolio TA, Psaty BM (Department of Public Health Sciences, Bowman Gray School of Medicine, Winston‐Salem, NC, Epidemiology and Biometry Program, Division of Epidemiology and Clinical Applications. National Heart, Lung and Blood Institute, Bethesda, MD, Department of Medicine, Epidemiology and Health Services, University of Washington, Seattle. WA, USA; Department of Medicine, Lund University, Malmo, Sweden). Overtreatment and undertreatment of hypertension (Frontiers in medicine). Journal of Internal Medicine 1994; 235 : 387–397. Results from a large number of randomized clinical trials document conclusively that treatment of elevated systolic and/or diastolic blood pressure markedly reduces the risk of cardiovascular complications such as stroke and acute myocardial infarction. Detection, treatment and control of hypertension have major public health implications. A review of the literature suggests the existence of both overtreatment (defined as improper or incorrect diagnosis of hypertension, overaggressive and potentially dangerous blood pressure lowering and the use of expensive antihypertensive drugs with unproven mortality/morbidity benefits) and undertreatment (defined as unrecognized, untreated and poorly controlled hypertension). These current major issues in medicine are discussed.